Di Fazio P - Search Results

1

The epitranscriptome: At the crossroad of cancer prognosis.

Di Fazio P. Di Fazio P. EBioMedicine. 2021 Feb;64:103231. doi: 10.1016/j.ebiom.2021.103231. Epub 2021 Jan 28. EBioMedicine. 2021. PMID: 33517076 Free PMC article. No abstract available.

2

Endoplasmic Reticulum Stress in Pancreatic Neuroendocrine Tumors is Linked to Clinicopathological Parameters and Possible Epigenetic Regulations.

Klieser E, Illig R, Státtner S, Primavesi F, Jáger T, Swierczynski S, Kiesslich T, Kemmerling R, Bollmann C, Di Fazio P, Neureiter D. Klieser E, et al. Among authors: di fazio p. Anticancer Res. 2015 Nov;35(11):6127-36. Anticancer Res. 2015. PMID: 26504039

3

Effects of multi and selective targeted tyrosine kinase inhibitors on function and signaling of different bladder cancer cells.

Hänze J, Kessel F, Di Fazio P, Hofmann R, Hegele A. Hänze J, et al. Among authors: di fazio p. Biomed Pharmacother. 2018 Oct;106:316-325. doi: 10.1016/j.biopha.2018.06.110. Epub 2018 Jul 11. Biomed Pharmacother. 2018. PMID: 29966976

4

Selumetinib Activity in Thyroid Cancer Cells: Modulation of Sodium Iodide Symporter and Associated miRNAs.

Wächter S, Wunderlich A, Greene BH, Roth S, Elxnat M, Fellinger SA, Verburg FA, Luster M, Bartsch DK, Di Fazio P. Wächter S, et al. Among authors: di fazio p. Int J Mol Sci. 2018 Jul 17;19(7):2077. doi: 10.3390/ijms19072077. Int J Mol Sci. 2018. PMID: 30018229 Free PMC article.

5

Pancreatic cancer cells surviving gemcitabine treatment express markers of stem cell differentiation and epithelial-mesenchymal transition.

Quint K, Tonigold M, Di Fazio P, Montalbano R, Lingelbach S, Rückert F, Alinger B, Ocker M, Neureiter D. Quint K, et al. Among authors: di fazio p. Int J Oncol. 2012 Dec;41(6):2093-102. doi: 10.3892/ijo.2012.1648. Epub 2012 Oct 1. Int J Oncol. 2012. PMID: 23026911

6

The pan-deacetylase inhibitor panobinostat suppresses the expression of oncogenic miRNAs in hepatocellular carcinoma cell lines.

Henrici A, Montalbano R, Neureiter D, Krause M, Stiewe T, Slater EP, Quint K, Ocker M, Di Fazio P. Henrici A, et al. Among authors: di fazio p. Mol Carcinog. 2015 Aug;54(8):585-97. doi: 10.1002/mc.22122. Epub 2013 Dec 23. Mol Carcinog. 2015. PMID: 24375802

7

Roscovitine has anti-proliferative and pro-apoptotic effects on glioblastoma cell lines: A pilot study.

Kolodziej M, Goetz C, Di Fazio P, Montalbano R, Ocker M, Strik H, Quint K. Kolodziej M, et al. Among authors: di fazio p. Oncol Rep. 2015 Sep;34(3):1549-56. doi: 10.3892/or.2015.4105. Epub 2015 Jul 3. Oncol Rep. 2015. PMID: 26151768

8

3-Deazaneplanocin A May Directly Target Putative Cancer Stem Cells in Biliary Tract Cancer.

Mayr C, Wagner A, Stoecklinger A, Jakab M, Illig R, Berr F, Pichler M, Di Fazio P, Ocker M, Neureiter D, Kiesslich T. Mayr C, et al. Among authors: di fazio p. Anticancer Res. 2015 Sep;35(9):4697-705. Anticancer Res. 2015. PMID: 26254359

9

The BMI1 inhibitor PTC-209 is a potential compound to halt cellular growth in biliary tract cancer cells.

Mayr C, Wagner A, Loeffelberger M, Bruckner D, Jakab M, Berr F, Di Fazio P, Ocker M, Neureiter D, Pichler M, Kiesslich T. Mayr C, et al. Among authors: di fazio p. Oncotarget. 2016 Jan 5;7(1):745-58. doi: 10.18632/oncotarget.6378. Oncotarget. 2016. PMID: 26623561 Free PMC article.

10

Pharmacological Inhibition of Class IIA HDACs by LMK-235 in Pancreatic Neuroendocrine Tumor Cells.

Wanek J, Gaisberger M, Beyreis M, Mayr C, Helm K, Primavesi F, Jäger T, Di Fazio P, Jakab M, Wagner A, Neureiter D, Kiesslich T. Wanek J, et al. Among authors: di fazio p. Int J Mol Sci. 2018 Oct 12;19(10):3128. doi: 10.3390/ijms19103128. Int J Mol Sci. 2018. PMID: 30321986 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

79 results

Search Page

Filters